IRPSX
Price
$10.39
Change
-$0.06 (-0.57%)
Updated
Sep 5 closing price
Net Assets
285.43M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

IRPSX vs VVIAX

Header iconIRPSX vs VVIAX Comparison
Open Charts IRPSX vs VVIAXBanner chart's image
VY® T. Rowe Price Equity Income S
Price$10.39
Change-$0.06 (-0.57%)
VolumeN/A
Net Assets285.43M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
IRPSX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IRPSX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRPSX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. IRPSX (285M). VVIAX pays higher dividends than IRPSX: VVIAX (2.10) vs IRPSX (1.56). IRPSX was incepted earlier than VVIAX: IRPSX (37 years) vs VVIAX (25 years). IRPSX (0.89) is less costly to investors than VVIAX (0.05). IRPSX is a more actively managed with annual turnover of: 21.00 vs. VVIAX (9.00). IRPSX has a lower initial minimum investment than VVIAX: IRPSX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. IRPSX (-3.34). VVIAX return over 5 years is better than : 70.16 vs. IRPSX (31.95).
IRPSXVVIAXIRPSX / VVIAX
Total Expense Ratio0.860.051,720%
Annual Report Gross Expense Ratio0.890.051,780%
Fund Existence37 years25 years-
Gain YTD-2.7937.850-36%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets285M203B0%
Annual Yield % from dividends1.562.1074%
Returns for 1 year-3.347.74-43%
Returns for 3 years9.6036.6126%
Returns for 5 years31.9570.1646%
Returns for 10 years-1.79131.61-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity